173 related articles for article (PubMed ID: 15206203)
1. [Taxanes as adjuvants in breast cancer. What repercussions will this have in clinical practice?].
Mosconi AM; Montedoro M
Suppl Tumori; 2004; 3(4):S18-20. PubMed ID: 15206203
[No Abstract] [Full Text] [Related]
2. [Taxanes in the adjuvant and neoadjuvant therapy of breast cancer].
Semiglazov VF; Semiglazov VV; Bozhok AA; Mel'nikova OA
Vopr Onkol; 2004; 50(2):243-9. PubMed ID: 15176231
[No Abstract] [Full Text] [Related]
3. [Metastatic breast cancer: is global survival increase a realistic endpoint in phase III clinical trials? Studies on taxanes; studies on trastuzumab. What repercussions will they have in clinical practice?].
Colozza M
Suppl Tumori; 2004; 3(4):S67-9. PubMed ID: 15206217
[No Abstract] [Full Text] [Related]
4. Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patients.
Vici P; Viola G; Botti C; Rossi S; Vitucci C; Corsetti S; Di Lauro L; Sergi D; Foggi P; Perri P; Tirelli C; Mottolese M; Fattoruso SI; Lopez M
Clin Ter; 2008; 159(6):449-52. PubMed ID: 19169607
[TBL] [Abstract][Full Text] [Related]
5. Drug treatments for adjuvant chemotherapy in breast cancer: recent trials and future directions.
Dang CT
Expert Rev Anticancer Ther; 2006 Mar; 6(3):427-36. PubMed ID: 16503859
[TBL] [Abstract][Full Text] [Related]
6. Taxanes: impact on breast cancer therapy.
Bachegowda LS; Makower DF; Sparano JA
Anticancer Drugs; 2014 May; 25(5):512-21. PubMed ID: 24552749
[TBL] [Abstract][Full Text] [Related]
7. [Taxanes in neojuvant radio-, chemoradio- and chemotherapy for breast cancer].
Bozhok AA; Semiglazov VF; Kletzel' AE; Arzumanov AS; Mel'nikova OA; Paltuev RM; Ivanova OA; Semiglazov VV
Vopr Onkol; 2006; 52(1):7-14. PubMed ID: 16715697
[No Abstract] [Full Text] [Related]
8. Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer.
Bedard PL; Di Leo A; Piccart-Gebhart MJ
Nat Rev Clin Oncol; 2010 Jan; 7(1):22-36. PubMed ID: 19997076
[TBL] [Abstract][Full Text] [Related]
9. [Role of taxanes in treatment of breast cancer].
Gorbunova VA; Besova NS
Vopr Onkol; 2004; 50(4):492-500. PubMed ID: 15605777
[No Abstract] [Full Text] [Related]
10. [The development of breast cancer therapy in Germany in 2004].
Haller U; Winter R; Untch M
Gynakol Geburtshilfliche Rundsch; 2004 Apr; 44(2):61-2. PubMed ID: 15067227
[No Abstract] [Full Text] [Related]
11. Controversies in the adjuvant treatment of breast cancer: the role of taxanes.
Di Leo A; Ciarlo A; Panella M; Pozzessere D; Santini S; Vinci E; Biganzoli L
Ann Oncol; 2004; 15 Suppl 4():iv17-21. PubMed ID: 15477303
[No Abstract] [Full Text] [Related]
12. [AIOM Conference 2004. Docetaxel: a recent conquest in the adjuvant therapy of breast cancer].
Adamo V
Tumori; 2004; 90(6):13-21. PubMed ID: 15762373
[No Abstract] [Full Text] [Related]
13. [So that survival chances in breast cancer are improved. Finding a "clinical trial opportunity" for your patients].
Vetter C
MMW Fortschr Med; 2003 Apr; 145(16):14. PubMed ID: 14606393
[No Abstract] [Full Text] [Related]
14. [Breast carcinoma. Preoperative chemotherapy can preserve the breast].
MMW Fortschr Med; 2002 Oct; 144(42):63. PubMed ID: 12534003
[No Abstract] [Full Text] [Related]
15. [The ATAC study on adjuvants in breast cancer. What kind of repercussions will it have on clinical practice?].
Gamucci T
Suppl Tumori; 2004; 3(4):S16. PubMed ID: 15206201
[No Abstract] [Full Text] [Related]
16. Taxanes in the treatment of early breast cancer.
Ring AE; Ellis PA
Cancer Treat Rev; 2005 Dec; 31(8):618-27. PubMed ID: 16266787
[TBL] [Abstract][Full Text] [Related]
17. [Taxotere application in the management of breast cancer].
Bozhok AA; Semiglazov VF; Kletcel' AE; Arzumanov AS; Ivanova OA; Semiglazov VV
Vopr Onkol; 2005; 51(2):253-60. PubMed ID: 16223013
[No Abstract] [Full Text] [Related]
18. [Metastatic breast cancer: is global survival increase a realistic endpoint in phase III clinical trials? Studies on taxanes; studies on trastuzumab].
Bria E; Vanni B; Cuppone F; Calabretta F; Campanella C; Torsello A; Terzoli E
Suppl Tumori; 2004; 3(4):S65-6. PubMed ID: 15206216
[No Abstract] [Full Text] [Related]
19. Adjuvant use of taxanes for patients with breast cancer: we see the tip of the iceberg.
Hudis C
Clin Breast Cancer; 2002 Dec; 3(5):326-32. PubMed ID: 12533262
[TBL] [Abstract][Full Text] [Related]
20. [The role of taxanes in breast cancer chemotherapy: what's new 15 years after?].
Herceg D; Vrbanec D
Lijec Vjesn; 2009; 131(5-6):133-41. PubMed ID: 19642533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
